New dengue drug trial aims to shorten illness and lower virus levels
NCT ID NCT07576868
First seen Jun 27, 2026 · Last updated Jul 10, 2026 · Updated 1 time
Summary
This study tests a new medicine called CP-COV03 in adults with dengue fever. The goal is to see if it can safely lower the amount of virus in the blood and help people feel better faster. About 210 participants will receive either the drug or a placebo. The trial is currently recruiting.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DENGUE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
The National Hospital of Tropical Diseases (NHTD)
RECRUITINGHanoi, Vietnam
-
Tien Giang Provincial General Hospital
RECRUITINGMỹ Tho, Vietnam
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Scientists deliberately infect volunteers with dengue to unlock immune secrets
- Could papaya leaves help fight dengue? new trial tests the idea
- Dengue danger linked to leaky gut? new study investigates
- Exercise program aims to restore strength after dengue and chikungunya
- Can existing COVID drug beat dengue? new trial begins
- Can WhatsApp messages stop dengue? new study tests digital health in colombia